MiR-320d Inhibits Progression of EGFR-Positive Colorectal Cancer by Targeting TUSC3

Conclusion: Generally, our results demonstrated that miR-320d could inhibit the malignant phenotype of EGFR-positive CRC through targeting TUSC3. The miR-320d might be a potential therapeutic target for EGFR-positive CRC.
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research